IRSp53 Inhibitors

IRSp53 Inhibitors form a group of compounds conceptualized to modulate the activity of the Insulin Receptor Substrate p53 (IRSp53), also known as BAIAP2. This protein plays a pivotal role in actin cytoskeleton remodeling, which is essential for various cellular processes such as cell shape, motility, and adhesion. The inhibitors in this class are designed to target either IRSp53 directly or the signaling pathways and molecular interactions it is involved in.

These inhibitors are diverse in their mechanisms, reflecting the multifaceted nature of IRSp53's functions. For instance, some inhibitors target GTPases like Rac1 and Cdc42, which are known to interact with IRSp53, thereby influencing the actin dynamics and cellular processes controlled by IRSp53. Others aim at modulating the kinases like ROCK and Pak1 or components like the Arp2/3 complex, which are integral to the actin cytoskeleton organization and thus indirectly affect IRSp53's function. The inhibitors also include compounds that stabilize or disrupt actin filaments, like Jasplakinolide and Cytochalasin D, as well as molecules that influence actin-binding proteins like cortactin and profilin.